Trademark: 87260401
Word
IGNYTA
Status Date
Monday, July 23, 2018
Filing Date
Wednesday, December 7, 2016
Published for Opposition
Tuesday, April 25, 2017
Abandoned Date
Monday, July 23, 2018
5 House mark for pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disorders
42 Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; medical and scientific research in the fields of treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disorders
The color(s) blue, white, and red is/are claimed as a feature of the mark.
The mark consists of white letters "ignyta" where the letter "t" is topped with the color red, with a blue background.
Aug 22, 2018
Automatic Update Of Assignment Of Ownership
Jul 23, 2018
Abandonment Notice Mailed - No Use Statement Filed
Jul 23, 2018
Abandonment - No Use Statement Filed
May 15, 2018
Withdrawal Of Attorney Granted
May 15, 2018
Teas Withdrawal Of Attorney Received
Sep 16, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 16, 2017
Corrected Noa E-Mailed
Sep 15, 2017
Extension 1 Granted
Aug 15, 2017
Extension 1 Filed
Sep 15, 2017
Divisional Processing Complete
Aug 15, 2017
Divisional Request Received
Aug 31, 2017
Case Assigned To Intent To Use Paralegal
Aug 15, 2017
Teas Request To Divide Received
Aug 15, 2017
Teas Extension Received
Jun 21, 2017
Noa E-Mailed - Sou Required From Applicant
Apr 25, 2017
Official Gazette Publication Confirmation E-Mailed
Apr 25, 2017
Published For Opposition
Apr 5, 2017
Notification Of Notice Of Publication E-Mailed
Mar 10, 2017
Approved For Pub - Principal Register
Mar 9, 2017
Assigned To Examiner
Dec 12, 2016
New Application Office Supplied Data Entered In Tram
Dec 10, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
